Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Results tend to build gradually, so you shouldnt expect to see or feel dramatic changes within the first few weeks
Patients should be advised to report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
In a post-hoc analysis of the SURPASS-4 trial, tirzepatide decreased albuminuria (protein in urine, a marker of kidney damage) and nearly halved the risk of a composite kidney endpoint compared to insulin glargine
Never take more than your prescribed dose
US$ 20.58
US$ 20.13
US$ 25.73
US$ 26.07
US$ 23.52
